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is a history of YF-outbreak; and our result on entomological risk
assessment foresees resurgence.
Methods & Materials: A total of 164, 085 female adult
mosquitoes were caught and pool-screened using polymerase
chain reaction for YF and DEN infections in two Nigerian States
(Benue and Bayelsa) between 2010 and 2011. Similarly, a total
of 431,381 larvae were collected in only Benue for entomologi-
cal risk assessments (house, container, Breteau indices) with the
determination of the transovarial status of some immature Aedes
mosquitoes across studied locations.
Results: In Benue, Aedes luteocephalus, Ae. aegypti and Anopheles
gambiaewere positive for YF.Meanwhile nomosquitowas positive
for DEN virus in Benue. For Bayelsa, only Mansonia africana was
positive for DEN-3 virus as against negative results of all screened
mosquitoes for YF. Entomological risk indicators suggest that three
(Oju, Ega and Otukpo) of the four communities surveyed in Benue
are at the verge of YF-epidemic. Evidence of a possible transovarial
transmission was seen in Ae. aegypti from Ega only.
Conclusion: These communities shouldbeplacedonahighalert
of a possible epidemic; and so, urgent step to clear the areas of
potential mosquito sites is highly recommended.
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Background: The dermotrophic variant of L donovani causes
cutaneous leishmaniasis (CL) in Sri Lankanpatients. Standard treat-
ment is painful, costly, repeated intra-lesional (IL) injections of
sodium stibogluconate (SSG). Treatment failures are increasingly
reported, hence the need to investigate alternatives. Thermother-
apy is a tested treatment for L tropica and Lmajor CL. Efﬁcacy, safety
and cost-beneﬁt of thermotherapy were assessed for the ﬁrst time,
for L.donovani CL.
Methods & Materials: Laboratory-conﬁrmed CL patients with
single lesions were randomly assigned to (i) test group (n=98;
received a single session of radio-frequency induced heat ther-
apy (RFHT) at 50 ◦C for 30 seconds) and (ii) control group (n=115;
received weekly IL- SSG until cure or 10 doses). Patients were
followed-up fortnightly for 12weeks to assess clinical response and
adverse events. Cost of treatment was assessed using the scenario
building technique.
Results: Cure rates by 8, 10 and 12 weeks in the thermotherapy
group were 46.5%, 56.5% and 65.9% as opposed to 28%,40.8% and
59.4% in IL-SSGgroup. Cure rateby thermotherapywas signiﬁcantly
higher (p =0.009) at 8 weeks and (p=0.035) at 10 weeks, while
comparable thereafter. Response to thermotherapy at 8 weeks was
signiﬁcantly higher in females [OR 1.93 (95% CI 0.997–3.738)],
papular lesions [OR2.73(95%CI 1.29–5.77)] and in lesions <2 cm[OR
1.95 (95% CI 0.98-3.87)] compared with IL SSG (p=0.05, p=0.009
and p=0.05). No major adverse events were recorded. It was 8.8
times cheaper to use thermotherapy (LKR164.00/patient) than IL
SSG (LKR1453.00/patient).
Conclusion: A single application of thermotherapy was safe,
cost-effective and convenient as compared to multiple doses of IL
SSG in treatment of L donovani CL.
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Background: Miltefosine is the only orally administrable drug
for the treatment of leishmaniasis. It is used as a ﬁrst line drug
for the Kala-azar Elimination Programme in the Indian subconti-
nent. But in recent years, a decline in its efﬁcacy points toward
the emergence of resistance to this drug. Knowledge of biomarkers
for miltefosine resistance may be beneﬁcial for proper selection of
treatment regimen.
Microarray-based gene expression proﬁle of miltefosine
relapsed parasites over sensitive strains
Differential gene expression of A. Calpain family cysteine
protease-like protein and B. hypothetical protein 2 using quali-
tative real time RT-PCR
